Ministry of AYUSH has taken cognizance of the news in the media about Ayurvedic medicines developed for the treatment of COVID-19 by Patanjali Ayurved Ltd, Haridwar (Uttrakhand). The ministry said that facts of the claim and details of the stated scientific study are not known to it.
“Patanjali Ayurved Ltd has been asked to provide at the earliest details of the name and composition of the medicines being claimed for COVID treatment; site(s)/hospital(s), where the research study was conducted for COVID-19; protocol, sample size, Institutional Ethics Committee clearance, CTRI registration and results data of the study (ies) and stop advertising/publicizing such claims till the issue is duly examined,” the Ministry of AYUSH said in a press release.
The ministry has also asked the Uttarakhand government to provide copies of license and approval details granted for the manufacture of Coronil. Patanjali is headquartered in Haridwar, which comes under Uttarakhand’s jurisdiction.
“Ministry has also requested concerned State Licensing Authority of Uttrakhand Government to provide copies of license and product approval details of the Ayurvedic medicines being claimed for the treatment of COVID -19,” the statement added.
Launching its product earlier Tuesday, Patanjali claimed that the medicine can cure COVID-19 within 14 days. “Facts of the claim and details of the stated scientific study are not known to the Ministry,” the Ministry of AYUSH statement added.
A majority of coronavirus patients recover without medication within 14 days. Drugs and other intrusive medication is administered in extreme cases.
More than 425,000 people have been infected with coronavirus in India and upwards of 14,000 casualties have been recorded in the country. Globally, the infection tally has crossed the nine million mark while the death toll has climbed upwards of 470,000.No drug or vaccine for the deadly virus has been discovered so far, albeit Gilead Sciences’ medicine, remdesivir, has been found to reduce the amount of time COVID-19 patients spend in hospital.